The Food and Drug Administration announced it will fund a campaign led by the Washington-based National Consumers League to address poor medication adherence.
FDA looks to boost medication adherence
The grant money, which will be administered by the FDA's Center for Drug Evaluation and Research, will allow the NCL to organize and lead a multistakeholder initiative supported by healthcare professionals, health IT companies, government agencies and other parties to raise consumer awareness of the issue, according to the FDA's notice in today's Federal Register.
Nearly 75% of Americans report failing to take medications as directed, and one in three people never fill their prescriptions, according to the notice. "Understanding the root causes for inadequate medication adherence, and effecting change in knowledge and behaviors to increase appropriate medication adherence and thus enhance health outcomes is an important goal for all Americans," the FDA noted in the notice.
The FDA said it would not open competition for the grant money to other organizations because the National Consumers League had “unique expertise and capacity found nowhere else.” The NCL has already brought together a group of more than 100 stakeholder organizations to work together on the campaign.
The efforts will be targeted to patients with chronic diseases as well as those living in six strategic markets, according to the FDA. The grant funding is guaranteed for one year with the possibility of more money during the second and third year, pending performance.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.